🇺🇸 Haloperidol + lorazepam in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Agitation — 1 report (10%)
2. Alanine Aminotransferase Increased — 1 report (10%)
3. Amnesia — 1 report (10%)
4. Anorexia — 1 report (10%)
5. Aspartate Aminotransferase Increased — 1 report (10%)
6. Body Temperature Increased — 1 report (10%)
7. Bone Marrow Failure — 1 report (10%)
8. Dehydration — 1 report (10%)
9. Headache — 1 report (10%)
10. Hypokinesia — 1 report (10%)

Source database →

Frequently asked questions

Is Haloperidol + lorazepam approved in United States?

Haloperidol + lorazepam does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Haloperidol + lorazepam in United States?

University of Arkansas is the originator. The local marketing authorisation holder may differ — check the official source linked above.